2019 Pharmaceutical Industry and Regulators Symposium Recording - Day 1, Part 2
This video is a recording of the second two presentations given at the 2019 Pharmaceutical Industry and Regulators Symposium in May 2019.
Presentation 1: Valsartan – Implications.
Dr. Andy Teasdale, AstraZeneca, Senior Principal Scientist
Presentation 2: In silico prediction of Mutagenicity.
Antonio Anax, Kimberly-Clark Corporation, Principal Toxicologist